New Hepatitis Meds Are Saving Lives: Study

New (and pricey) hepatitis C medicines, such as Harvoni and Sovaldi, are living up to their promise and greatly reducing patients' odds for liver cancer and death, a new French study finds.

from General Cancer News Articles Provided by Cancer Compass http://bit.ly/2tkAoms